Screener
EBIT at other companies
Other financials
Where this comes from
Calculated from Rhythm Pharmaceuticals, Inc.’s reported figures.
The source filing: Rhythm Pharmaceuticals, Inc.’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-030549
FAQ
- What is Rhythm Pharmaceuticals, Inc.'s EBIT?
- Rhythm Pharmaceuticals, Inc. (RYTM) reported EBIT of -$52.36M in Q1 2026.
- How has Rhythm Pharmaceuticals, Inc.'s EBIT changed year-over-year?
- Rhythm Pharmaceuticals, Inc.'s EBIT decreased by 11.4% year-over-year, from -$47M to -$52.36M.
- What is the long-term trend for Rhythm Pharmaceuticals, Inc.'s EBIT?
- Over 4 years (2021 to 2025), Rhythm Pharmaceuticals, Inc.'s EBIT has grown at a 3.1% compound annual growth rate (CAGR), from -$170.06M to -$192.02M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.
Ask your AI about Rhythm Pharmaceuticals, Inc.'s ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude